We are thrilled to announce a groundbreaking scientific study authored by Mathieu Frechin and Daniel Olive, in collaboration with Aix Marseille Université, ImCheck therapeutics, and Nanolive. Their remarkable research on Vγ9Vδ2 T cells has opened up new possibilities...
On June 20th, Nanolive has launched another ground-breaking tool in cell analysis: the LIVE Cytotoxicity Assay, an AI-powered digital assay with fluorescent labelling that monitors the responses of different cell lines in co-culture simultaneously. For this event, we...
We are happy to see that Nanolive imaging has been used to confirm the success of another new therapy, this time treating melasma. In their latest paper “Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved...
The Roselli Lab at the University of Ulm have been researching potential avenues to reduce neuronal death after traumatic brain injury, and uncovered a key role for interleukin-13, published in Nature Communications this month (Interleukin-13 and its receptor are...
Showcasing our AI-powered digital cytotoxicity and cell viability assay, we demonstrate how Nanolive’s high-content live cell imaging can be used to increase confidence in lead candidate selection. Watch the webinar on-demand In this webinar, we explore the...
